Evolution of the bioartificial liver: The need for randomized clinical trials

The American Journal of Surgery

Volumn 166, Issue 5, 1993, Pages 512-521

  Nyberg, Scott L ^a   Peshwa, Madhusudan V ^a   Payne, William D ^a   Hu, Wei Shou ^a   Cerra, Frank B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL;

ARTIFICIAL LIVER; BIOREACTOR; CELL CULTURE; CELL SUSPENSION; CELL TRANSPLANTATION; CLINICAL TRIAL; DOG; EXCHANGE BLOOD TRANSFUSION; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HEMOPERFUSION; HUMAN; IMPLANTATION; LIVER CELL; LIVER FAILURE; LIVER PERFUSION; MICROENCAPSULATION; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW;

ANIMAL; ARTIFICIAL ORGANS; HUMAN; LIVER; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027713285     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(05)81146-8     Document Type: Article

References (106)

1. Exchange transfusion in hepatic coma: report of a case
2. Ammonia intoxication treated by hemodialysis
3. The artificial liver experiments and clinical application
4. Births, marriages, divorces, and deaths for 1990
5. Evolution and future perspectives for reduced-size hepatic transplantation
6. Quality of life before and after orthotopic heaptic transplantation
7. Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit
8. Liver transplantation: initial experience in the Veterans Administration
9. The first 100 liver transplants at UCLA
10. Liver transplantation in children: the Boston Center experience in the first 30 months
11. Artificial liver: state of the art
12. Mammalian hepatocytes as a foundation for treatment in human liver failure
13. Hepatic failure coma treated by polyacrylonitrile membrane hemodialysis
14. Heterologous liver perfusion in treatment of hepatic failure
15. Use of perfused cadaveric liver in the management of hepatic failure
16. Successful application of extracorporeal liver perfusion for the treatment of fulminant hepatic failure: a technology whose time has come
17. Long-term hepatic support by intermittent multi-species liver perfusions
18. Development of a hybrid bioartificial liver
19. Acute hepatic coma treated by cross-circulation or exchange transfusion
20. Treatment of severe barbiturate poisioning
21. Haemoperfusions over a microencapsulated adsorbent in a patient with hepatic coma
22. Charcoal haemoperfusion in the treatment of fulminant hepatic failure
23. Severe hepatic failure: a critical study of current therapy
24. Clinical experience with ACAC coated charcoal hemoperfusion in acute intoxication
25. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review
26. Clinical experience with charcoal and resin hemoperfusion
27. Temporary liver support using a new type of sorbent. A urethane sheet embedded with powdered charcoal
28. Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy
29. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands
30. Charcoal hemoperfusion. Plus ca change, plus c'est la même chose
31. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
32. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the Biologic-DT)
33. Liver support system used sorbent urethane sheet embedded with powdered charcoal
34. Treatment of hepatic coma by exchange blood transfusion
35. Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange)
36. Plasmapheresis with albumin as main substitute in acute hepatic come
37. Plasmapheresis in a patient with hepatic failure awaiting liver transplantation
38. Hepatic assist device, using membrane plasma separator and dialyzer
39. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis
40. Fulminant hepatitis: Mayo Clinic experience with 34 cases
41. Enzymatic detoxification using lipophilic hollow-fiber membranes: I. Glucuronidation reactions
42. Enzymatic detoxification using lipophilic hollow-fiber membranes: II. Sulfation reactions
43. Enzymatic removal of bilirubin from blood: a potential treatment for neonatal jaundice
44. Enzymatic detoxification using lipophilic hollow-fiber membranes: III. Oxidation reactions of sulfides
45. Successful treatment of hepatic coma by a new artificial liver device in the pig
46. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes
47. Hybrid bioartificial liver in hepatic failure: preliminary clinical report
48. Neonatal hepatocyte culture on artificial capillaries: a model for drug metabolism and the artificial liver
49. Use of liver slices for an artificial liver
50. Immunoprotection of xenocytes in a hollow fiber bioartificial liver
51. Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes
52. Use of a novel bioartificial liver in a patient with acute liver insufficiency
53. Thrombosis in extracorporeal devices
54. Culturing hepatocytes and other differentiated cells
55. Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures
56. Influence of medium composition on 7-alkoxycoumarin O-dealkylase activities of rat hepatocytes in primary maintenance culture
57. Mitogens and hepatocyte growth control in vivo and in vitro
58. Methods for growth of cultured cells in serum-free medium
59. Effects of extracellular matrix on hepatocyte growth and gene expression: implications for hepatic regeneration and the repair of liver injury
60. Influence of different substrates in detoxification activity of adult rat hepatocytes in long-term culture: implications for transplantation
61. Prolonged maintainance of active cytochrome P-450 in adult rat hepatocytes co-cultured with another liver cell type
62. Long-term maintenance of hepatocyte functional activity in co-culture: requirements for sinusoidal endothelial cells and dexamethasone
63. Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation
64. Reversal of fulminant hepatic failure using an extracorporeal liver assist device
65. Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats
66. Hepatocyte transplantation in man
67. Hepatocyte transplantation: back to the future
68. Large-scale production and cultivation of hepatocytes on Biosilon microcarriers
69. Hepatocyte transplantation: a potential treatment for liver disease
70. Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities
71. Transplantation of spheroidal aggregate cultured hepatocytes into the rat spleen
72. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments
73. Microencapsulated hepatocytes: an in vitro and in vivo study
74. Release of hepatic stimulatory substance from cultures of free and microencapsulated hepatocytes: preliminary report
75. Microencapsulated hepatocytes for bioartificial liver support
76. Selective cell transplantation using bioabsorbable artificial polymers as matrices
77. Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats
78. New method of hepatocyte transplantation and extracorporeal liver support
79. An experimental artificial liver utilizing extracorporeal metabolism with sliced or granulated canine liver
80. Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer
81. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers
82. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries
83. Use of hepatocytes in adhesion and suspension cultures for liver support bioreactors
84. Temporary organ substitution by hemoperfusion through suspension of active donor hepatocytes in a total complex of intensive therapy in patients with acute hepatic insufficiency
85. Bioartificial liver using hepatocytes on Biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats
86. Development of bioartificial liver: bilirubin conjugation in Gunn rats
87. A two-compartment cell entrapment bioreactor with three different holding times for cells, high and low molecular weight compounds
88. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas
89. Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hydrid artificial pancreas
90. Renal epithelial cells grown on semipermeable hollow fibers as a potential ultrafiltrate processor
91. A bioartificial parathyroid
92. In vivo chamber culture technique
93. Reversible inhibition of albumin production by rat hepatocytes maintained on a laminin-rich gel (Engelbreth-Holm-Swarm) in response to secretory products of Kupffer cells and cytokines
94. Membranes as substrates for hepatocyte adhesion in liver support bioreactors
95. A hepatocyte bioreactor as a potential bioartificial liver: demonstration of prolonged tissue-specific functions
96. Evaluation of a hepatocyte entrapment hollow fiber bioreactor: a potential bioartificial liver
97. Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver
98. Demonstration of biochemical function by extracorporeal xeno-hepatocytes in an anhepatic animal model
99. Recovery of syncytial giant-cell (SGCH) hepatitis following treatment with an extracorporeal liver assist device (ELAD)
100. Improved liver function following treatment with an extracorporeal liver assist device
101. Letter to the editor
102. Extracorporeal membrane oxygenation and the play the winner rule
103. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study
104. Intensive liver care and management of acute hepatic failure
105. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure